Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

CHL1 PCDH12 PLXNB2 FAT2 PCDH15 NRCAM DSCAM PCDHGB2 CELSR1 HMCN1 CDH2 PCDHGC3 CDH10

3.94e-0818720113GO:0007156
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

CHL1 PCDH12 PLXNB2 FAT2 NRXN1 PCDH15 NRCAM DSCAM PCDHGB2 CELSR1 HMCN1 MDGA1 CDH2 PCDHGC3 CDH10

4.67e-0731320115GO:0098742
GeneOntologyBiologicalProcessregulation of cellular component biogenesis

IRGM ATP7A CC2D1A NUP62 MEFV ALMS1 NRXN1 NAE1 PKP2 ULK4 FLNA ABI3BP ARHGEF5 NTRK2 EPB41L5 ARHGEF18 AIDA SAR1A SHQ1 IKBKE CEP295 RP1 LIMCH1 C9orf72 MDGA1 FLOT1 BECN1

3.68e-05118920127GO:0044087
GeneOntologyBiologicalProcesscell-cell adhesion

CHL1 IRGM CLEC4M PCDH12 PLXNB2 FAT2 NRXN1 PCDH15 PKP2 HSPD1 FLNA NRCAM DSCAM KRT18 PCDHGB2 EPB41L5 FNDC3A GLMN CELSR1 HMCN1 MDGA1 FLOT1 CDH2 PCDHGC3 CDH10

5.15e-05107720125GO:0098609
GeneOntologyBiologicalProcessneuron migration

CHL1 KIAA0319L PLXNB2 ULK4 NIPBL FLNA NRCAM NTRK2 CELSR1 MDGA1

5.79e-0521820110GO:0001764
DomainCadherin_CS

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

2.11e-051091988IPR020894
Domain-

EPPK1 EVPL DST

2.29e-05619833.90.1290.10
DomainCADHERIN_1

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

2.74e-051131988PS00232
DomainCadherin

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

2.74e-051131988PF00028
DomainFN3

CHL1 KIAA0319L NRCAM DSCAM ABI3BP TNC FNDC3A ROS1 MDGA1 MYBPC1

2.90e-0518519810SM00060
DomainCADHERIN_2

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

2.92e-051141988PS50268
Domain-

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

2.92e-0511419882.60.40.60
DomainCA

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

3.11e-051151988SM00112
DomainCadherin-like

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

3.31e-051161988IPR015919
DomainCadherin

PCDH12 FAT2 PCDH15 PCDHGB2 CELSR1 CDH2 PCDHGC3 CDH10

3.74e-051181988IPR002126
DomainPlectin

EPPK1 EVPL DST

3.98e-0571983PF00681
DomainPlectin_repeat

EPPK1 EVPL DST

3.98e-0571983IPR001101
DomainPLEC

EPPK1 EVPL DST

3.98e-0571983SM00250
DomainFN3_dom

CHL1 KIAA0319L NRCAM DSCAM ABI3BP TNC FNDC3A ROS1 MDGA1 MYBPC1

8.11e-0520919810IPR003961
DomainTyr_kinase_rcpt_2_CS

ALK NTRK2 ROS1

1.82e-04111983IPR002011
DomainRECEPTOR_TYR_KIN_II

ALK NTRK2 ROS1

2.41e-04121983PS00239
DomainFN3

CHL1 NRCAM DSCAM ABI3BP TNC FNDC3A ROS1 MDGA1 MYBPC1

2.80e-041991989PS50853
DomainKINESIN_LIGHT

KLC2 KLC4

3.33e-0431982PS01160
DomainALMS_motif

ALMS1 CEP295

3.33e-0431982IPR029299
DomainALMS_motif

ALMS1 CEP295

3.33e-0431982PF15309
DomainKinesin_light_repeat

KLC2 KLC4

3.33e-0431982IPR015792
Domainfn3

CHL1 NRCAM DSCAM ABI3BP TNC FNDC3A ROS1 MYBPC1

3.40e-041621988PF00041
DomainATPase_dyneun-rel_AAA

MDN1 DNAH5 DNAH8

3.92e-04141983IPR011704
DomainAAA_5

MDN1 DNAH5 DNAH8

3.92e-04141983PF07728
DomainNeurofascin/L1/NrCAM_C

CHL1 NRCAM

6.62e-0441982IPR026966
DomainKinesin_light

KLC2 KLC4

6.62e-0441982IPR002151
DomainBravo_FIGEY

CHL1 NRCAM

6.62e-0441982PF13882
DomainHEAT_REPEAT

ULK4 NIPBL MROH2A ODAD2 PPP2R1A

8.82e-04701985PS50077
DomainIGc2

CHL1 PXDNL NRCAM DSCAM NTRK2 HMCN1 BCAM MDGA1 MYBPC1

9.31e-042351989SM00408
DomainIg_sub2

CHL1 PXDNL NRCAM DSCAM NTRK2 HMCN1 BCAM MDGA1 MYBPC1

9.31e-042351989IPR003598
DomainIg_I-set

CHL1 PXDNL NRCAM DSCAM NTRK2 HMCN1 MDGA1 MYBPC1

9.72e-041901988IPR013098
DomainI-set

CHL1 PXDNL NRCAM DSCAM NTRK2 HMCN1 MDGA1 MYBPC1

9.72e-041901988PF07679
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

EXPH5 CC2D1A NUP62 NEK1 DST MDN1 ALMS1 STARD9 PKP2 NR3C2 KIF2C VCPIP1 KRT18 TTC28 ARHGEF5 PSD3 KLC2 EPB41L5 KLC4 IPO9 SLC12A2 IKBKE LIMCH1 BECN1 AHNAK2

5.17e-118612032536931259
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

MARS1 NUP62 PSMD11 GEM NUP205 DST MDN1 ASCC3 PLOD2 COG4 HSPD1 FLNA KRT18 UPF1 HUWE1 FHIP2A LETM1 LRCH3 GLMN MYOF PPP2R1A IGF2BP1 AFAP1 IPO9 OXCT1 NAT10 LIMCH1 TRIM13 FLOT1 AHNAK2

1.59e-0914402033030833792
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FRMPD4 RAPGEF5 IFT172 PHF8 STARD9 MCM3AP VCPIP1 NRCAM TTC28 PSD3 ZYG11B FHIP2A BAZ2A LIMCH1 SENP7 PDZD2

2.73e-094072031612693553
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

FRMPD4 PLXNB2 MDN1 ALMS1 NRCAM CHD9 HUWE1 BAZ2A PDZD2

1.12e-0810420399205841
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

ZNF280A UBL7 EPPK1 ATP7A RAPGEF5 EXPH5 EVPL PSMD11 TTC1 PNMA5 KMT2C DST MDN1 ALDH3B2 COG4 KLHL6 FLNA TMEM176B TNC KLC2 SLC5A3 IGF2BP1 WDR41 BCAM FYB1 MYBPC1

4.41e-0812932032615342556
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

EPPK1 MARS1 MDN1 NIPBL KIF2C HSPD1 FLNA UPF1 HUWE1 PPP2R1A TSR1 NAT10 AHNAK2

9.19e-083322031332786267
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MARS1 PSMD11 PHF8 NUP205 DST MDN1 MCM3AP PKP2 ASCC3 NIPBL KIF2C HSPD1 FLNA KRT18 PLEKHG4 EPB41L5 UPF1 HUWE1 PPP2R1A IPO9 OXCT1 BAZ2A NAT10 YME1L1 AHNAK2 SORD

1.07e-0713532032629467282
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

BACH2 KIAA0319L CC2D1A NUP62 PHF8 TTC1 NUP205 ALMS1 VCPIP1 HSPD1 TTC28 KLC2 KLC4 FHIP2A GLMN MEIOC TSR1 CEP295 ZNF565 FLOT1

1.63e-078532032028718761
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

EPPK1 MARS1 NUP62 PSMD11 PLXNB2 SCAF4 NUP54 NUP205 DST MDN1 ASCC3 NIPBL HSPD1 FLNA KRT18 HUWE1 SAR1A PPP2R1A IGF2BP1 SLC12A2 NAT10 FLOT1

1.71e-0710242032224711643
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MARS1 EXPH5 SCAF4 KMT2C MDN1 SCN9A ASCC3 KIF2C KLC2 CHD9 PPP2R1A IKBKE RP1 LIMCH1 DNPEP

2.72e-074972031536774506
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

ATP7A KIAA0319L DMXL1 DST OSBPL1A ZDHHC13 COG4 FNDC3A LRCH3 SLC12A2 STEAP3 WDR41 TRIM13 C9orf72 YME1L1

3.25e-075042031534432599
Pubmed

DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors.

NRXN1 NRCAM DSCAM MDGA1 CDH2

3.84e-0726203534848499
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ATP7A CC2D1A TTC1 PLXNB2 DMXL1 MDN1 NAE1 ASCC3 PLOD2 HSPD1 PSD3 EPB41L5 FNDC3A UPF1 LETM1 SLC5A3 SLC12A2 BAZ2A TSR1 NAT10 STEAP3 WDR41 TRIM13 C9orf72 FLOT1 YME1L1

6.50e-0714872032633957083
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

EPPK1 MARS1 NUP62 PSMD11 NUP54 NUP205 HSPD1 FLNA KRT18 HUWE1 PPP2R1A IGF2BP1 ZMYM1 YME1L1

6.72e-074632031434901782
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

PSMD11 TTC1 PLXNB2 DST MDN1 ALMS1 KIF2C VCPIP1 HSPD1 TTC28 FNDC3A UPF1 HUWE1 LETM1 GLMN IGF2BP1 OXCT1 SLC12A2 BAZ2A NAT10 WDR41 TRIM13 C9orf72 FLOT1 YME1L1 AHNAK2

7.27e-0714962032632877691
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ATP7A KIAA0319L CC2D1A DMXL1 DST PKP2 HSPD1 DSCAM TTC28 EPB41L5 HUWE1 SAR1A PKHD1L1 IGF2BP1 SLC12A2 STEAP3 ZFHX3 WDR41

8.28e-077772031835844135
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

PHF8 KMT2C DST ALMS1 NRXN1 GPR158 TTC28 PSD3 FNDC3A MYOF

9.27e-072252031012168954
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

CC2D1A PHF8 SCAF4 KMT2C NEK1 ALMS1 ASCC3 VCPIP1 FLNA TTC28 UPF1 HUWE1 PPP2R1A BAZ2A NAT10

9.48e-075492031538280479
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

FRMPD4 DST ALMS1 NRXN1 MCM3AP NRCAM TTC28 PDZD2

1.04e-06130203812421765
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

MYO7B ZGRF1 FAT2 DST MDN1 FAM186A DNAH5 FLNA IGF2BP1 NAT10

1.32e-062342031036243803
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

MARS1 EVPL CC2D1A SCAF4 DST NIPBL MAP4K2 HSPD1 FLNA KRT18 SIPA1 AHNAK2

1.58e-063602031233111431
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

ALMS1 ATL2 COG4 VCPIP1 TTC28 EPB41L5 ARHGEF18 FNDC3A HUWE1 SAR1A GLMN SLC12A2 STEAP3 CEP295 WDR41 ZMYM1 TRIM13

1.67e-067332031734672954
Pubmed

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.

DST PLOD2 HSPD1 KRT18 PPP2R1A IPO9 OXCT1 HMCN1

2.02e-06142203830809309
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

TTC1 DST ALMS1 PKP2 KIF2C TTC28 KLC2 KLC4 LETM1 LRCH3 GLMN PPP2R1A CEP295

2.54e-064462031324255178
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

MARS1 NUP62 PSMD11 NUP205 MDN1 STARD9 ATL2 DNAH5 NIPBL HSPD1 FLNA UPF1 HUWE1 SAR1A LETM1 GLMN PPP2R1A IGF2BP1 IPO9 TSR1 NAT10 FLOT1 MYBPC1 DNPEP

3.45e-0614252032430948266
Pubmed

Human transcription factor protein interaction networks.

KLF12 MARS1 CC2D1A NUP62 PSMD11 PHF8 SCAF4 NUP54 NUP205 KMT2C DST ALMS1 NIPBL HSPD1 UPF1 PPP2R1A IGF2BP1 ZFHX4 NAT10 ZKSCAN3 ZFHX3 ZMYM1 FLOT1 SORD

3.61e-0614292032435140242
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

CHL1 EPPK1 MARS1 EXPH5 KMT2C DNAH5 VCPIP1 CHD9 RP1

4.08e-06208203933230847
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

OR1M1 ZNF174 NUP62 NUP54 NUP205 BMPR1A DST MDN1 NRXN1 STARD9 FAM186A SCN9A DNAH8 NIPBL HSPD1 FLNA ABI3BP KRT18 PCDHGB2 LETM1 CEP295 LIMCH1 PCDHGC3 MYBPC1

4.21e-0614422032435575683
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DST MDN1 NRXN1 GPR158 NIPBL KIF2C NRCAM DSCAM NTRK2 ARHGEF18 UPF1 HUWE1 SIPA1 LETM1 PPP2R1A NAT10 LIMCH1 CDH2 CDH10

4.26e-069632031928671696
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

MARS1 NUP205 ASCC3 FLNA TTC28 MYOF NAT10 LIMCH1 FLOT1 AHNAK2

4.43e-062682031033024031
Pubmed

Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.

MARS1 PSMD11 NUP205 MDN1 KIF2C HSPD1 FLNA KRT18 UPF1 SIPA1 SAR1A SLC5A3 PPP2R1A IGF2BP1 NAT10 FLOT1

4.63e-067072031619738201
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ATP7A MARS1 CC2D1A DST PKP2 ASCC3 KIF2C VCPIP1 HSPD1 TTC28 PSD3 EPB41L5 FNDC3A UPF1 LETM1 PPP2R1A

4.72e-067082031639231216
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

EPPK1 MARS1 EXPH5 EVPL NUP62 NUP54 NUP205 DST PKP2 ASCC3 KIF2C HSPD1 FLNA KRT18 UPF1 LRCH3 MYOF PPP2R1A AFAP1 TSR1 NAT10 FLOT1

4.96e-0612572032236526897
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

MARS1 IFT172 NUP62 PSMD11 NUP205 MDN1 ASCC3 HSPD1 FLNA UPF1 HUWE1 PPP2R1A IGF2BP1 IPO9 NAT10

5.90e-066382031533239621
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

EPPK1 DDAH1 PSMD11 NUP205 ZDHHC13 KIF2C HSPD1 FLNA KRT18 EPB41L5 SLC5A3 IPO9 OXCT1 CDH2

6.61e-065642031421565611
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

ZGRF1 NEK1 DST ALMS1 ASCC3 VCPIP1 FLNA TTC28 HUWE1 ZFHX4 ZKSCAN3 ZFHX3

7.25e-064182031234709266
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

MARS1 CC2D1A NUP62 TTC1 SCAF4 NEK1 DST ALMS1 NIPBL VCPIP1 HSPD1 FLNA KRT18 UPF1 IGF2BP1 BAZ2A NAT10 AHNAK2

1.06e-059342031833916271
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

EPPK1 FRMPD4 MARS1 DST PKP2 HSP90AA2P KIF2C HSPD1 FLNA KRT18 EPB41L5 UPF1 LRCH3 IGF2BP1 TSR1 NAT10 LIMCH1 FLOT1

1.31e-059492031836574265
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

EPPK1 MARS1 PSMD11 TTC1 SCAF4 DST MDN1 NAE1 ASCC3 PLOD2 HSPD1 FLNA KRT18 UPF1 HUWE1 PPP2R1A IGF2BP1 IPO9 TSR1 LIMCH1

1.48e-0511492032035446349
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

EPPK1 NUP62 NUP205 ASCC3 DNAH5 DNAH8 NIPBL VCPIP1 FNDC3A UPF1 HUWE1 IGF2BP1 OXCT1 YME1L1 SORD

1.87e-057042031529955894
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

KLF12 RAPGEF5 MARS1 PTCH1 TUB KMT2C BMPR1A ZNF780A COG4 KIF2C KLHL6 FLNA ARHGEF18 HUWE1 LETM1 TSR1 NAT10 CEP295 ZMYM1

2.22e-0510842031911544199
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

EPPK1 MARS1 DST MDN1 HSPD1 FLNA UPF1 HUWE1 SAR1A MYOF PPP2R1A SLC12A2 ZFHX3 AHNAK2 SORD DNPEP

2.36e-058072031630575818
Pubmed

The sperm-associated antigen 6 interactome and its role in spermatogenesis.

SCAF4 NUP54 NIPBL HSPD1 ZFP28 MEIOC WDR87 TNKS2

2.40e-05199203831146259
Pubmed

The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.

MARS1 NUP205 MDN1 PKP2 HSPD1 KRT18 PPP2R1A OXCT1 NAT10

2.58e-05262203936880596
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

EXPH5 ALMS1 VCPIP1 TTC28 EPB41L5 SLC12A2 MEIOC TRIM13 AHNAK2

2.66e-05263203934702444
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

NUP62 NUP54 NUP205 MCM3AP ASCC3 UPF1 HUWE1 BAZ2A TSR1 NAT10

2.83e-053322031025693804
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

EPPK1 MARS1 PSMD11 MDN1 HSPD1 KRT18 ZYG11B UPF1 HUWE1 SAR1A PPP2R1A IPO9 LIMCH1 YME1L1

3.02e-056472031426618866
Pubmed

AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

MARS1 NUP205 MDN1 ASCC3 HSPD1 FLNA UPF1 PPP2R1A IGF2BP1 SLC12A2 FLOT1 CDH2

3.08e-054842031231995728
Pubmed

A human MAP kinase interactome.

EXPH5 EVPL TTC1 NUP54 KMT2C DST MCM3AP COG4 HSPD1 FLNA ABI3BP KRT18

3.21e-054862031220936779
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

CC2D1A TTC1 DST VCPIP1 FLNA FNDC3A SLC12A2 STEAP3 LIMCH1 WDR41 TRIM13 C9orf72 AHNAK2

3.29e-055682031337774976
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

BACH2 PHF8 BMPR1A ALMS1 MCM3AP PKP2 ASCC3 ZDHHC13 TTC28 BTBD18 CHD9 SIPA1 ZFHX4 BAZ2A NAT10 ZFHX3 CEP295 YME1L1 SENP7

3.30e-0511162031931753913
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

EPPK1 NUP205 DST MDN1 MCM3AP ASCC3 NIPBL FLNA UPF1 HUWE1 PPP2R1A BAZ2A TSR1 NAT10

3.34e-056532031422586326
Pubmed

Adhesion molecules close homolog of L1 and tenascin-C affect blood-spinal cord barrier repair.

CHL1 TNC

3.39e-052203222473292
Pubmed

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma.

ALK ROS1

3.39e-052203224462463
Pubmed

Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export.

NUP54 C9orf72

3.39e-052203228069952
Pubmed

Different clinical features between patients with ROS1-positive and ALK-positive advanced non-small cell lung cancer.

ALK ROS1

3.39e-052203233583243
Pubmed

Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension.

DDAH1 TNFRSF11B

3.39e-052203221975354
Pubmed

Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples.

ALK ROS1

3.39e-052203233683692
Pubmed

UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction.

UPF1 C9orf72

3.39e-052203233789100
Pubmed

The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.

ZFHX4 ZFHX3

3.39e-052203210873665
Pubmed

Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule.

CHL1 NRCAM

3.39e-052203218588951
Pubmed

Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells.

ALK ROS1

3.39e-052203231392269
Pubmed

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.

ALK ROS1

3.39e-052203230943926
Pubmed

C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression.

UPF1 C9orf72

3.39e-052203232620797
Pubmed

Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever.

MEFV TNFRSF11B

3.39e-052203219346738
Pubmed

The cell adhesion molecule CHL1 interacts with patched-1 to regulate apoptosis during postnatal cerebellar development.

CHL1 PTCH1

3.39e-052203228630165
Pubmed

Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association.

ALK FLOT1

3.39e-052203224830726
Pubmed

Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm.

DNAH5 ODAD2

3.39e-052203224203976
Pubmed

Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers.

ALK ROS1

3.39e-052203227401242
Pubmed

Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.

ALK ROS1

3.39e-052203225789833
Pubmed

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.

ALK ROS1

3.39e-052203226152804
Pubmed

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.

ALK ROS1

3.39e-052203234686712
Pubmed

Capsaicin induces NKCC1 internalization and inhibits chloride secretion in colonic epithelial cells independently of TRPV1.

TRPV1 SLC12A2

3.39e-052203223139219
Pubmed

Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex.

NUP62 NUP54

3.39e-05220328589458
Pubmed

TRPV1 activation stimulates NKCC1 and increases hydrostatic pressure in the mouse lens.

TRPV1 SLC12A2

3.39e-052203232293931
Pubmed

Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma.

ALK ROS1

3.39e-052203229251734
Pubmed

ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.

ALMS1 CEP295

3.39e-052203230421101
Pubmed

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

BMPR1A GPR158 PCDH15 ODAD2 SEC31B TDRD1 SAR1A MYOF TNKS2 YME1L1 ZNF239

3.63e-054152031116385451
Pubmed

Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.

GEM PCDH15 NRCAM TNC SLC19A3 CPM

3.66e-05105203624667918
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

EPPK1 CC2D1A NUP205 ULK4 KIF2C HSPD1 FLNA FNDC3A UPF1 LETM1 MYOF NAT10 ROS1 LIMCH1 YME1L1

4.11e-057542031535906200
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

EPPK1 PSMD11 MDN1 NIPBL KIF2C HSPD1 UPF1 HUWE1 SHOC2 SEC31B PPP2R1A IPO9 NAT10

4.23e-055822031320467437
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

MARS1 PSMD11 PLXNB2 NUP205 ASCC3 PLOD2 VCPIP1 FLNA KRT18 FNDC3A UPF1 HUWE1 GLMN PPP2R1A IPO9 SLC12A2 YME1L1

4.26e-059422031731073040
Pubmed

BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

ASCC3 VCPIP1 TTC28 KLC2 MYOF IPO9 LIMCH1 AHNAK2

4.29e-05216203831519766
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

UBL7 MARS1 PSMD11 TTC1 NUP205 NAE1 PLOD2 VCPIP1 HSPD1 FLNA KRT18 KLC2 HUWE1 KLC4 PPP2R1A IPO9 OXCT1 TSR1 LIMCH1 AHNAK2 SORD DNPEP

4.64e-0514552032222863883
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

MARS1 PSMD11 BMPR1A PKP2 ASCC3 HSPD1 FLNA KRT18 KLC2 CHD9 UPF1 HUWE1 MYOF PPP2R1A IPO9 TSR1 WDR87 NAT10 LIMCH1 FLOT1

4.68e-0512472032027684187
Pubmed

Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.

DDAH1 PHF8 PLXNB2 SCAF4 PTRHD1 PKP2 DNAH8 HSPD1 UPF1 LETM1 MYOF PPP2R1A IGF2BP1 OXCT1 NEK11 PDZD2

4.97e-058592031631536960
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

CC2D1A SCAF4 NUP205 STARD9 MCM3AP PKP2 C5 ASCC3 PLOD2 ALK FLNA EPB41L5 CPM UPF1 IGF2BP1 IPO9 TSR1 NAT10 ROS1 LIMCH1 FLOT1

5.80e-0513712032136244648
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

ZGRF1 DST MDN1 FLNA TNC BTBD18 SAR1A MYOF SLC12A2 SENP7

5.98e-053632031014691545
Pubmed

Defining the membrane proteome of NK cells.

ATP7A MARS1 CC2D1A PSMD11 NUP205 MDN1 ASCC3 ATL2 ZDHHC13 KIF2C HSPD1 FLNA KLC2 FNDC3A HUWE1 IPO9 NAT10 FLOT1 YME1L1

6.05e-0511682031919946888
Pubmed

SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.

MARS1 PSMD11 NAE1 PLOD2 COG4 HSPD1 FLNA TRPV1 HUWE1 SAR1A SHQ1 PPP2R1A IPO9 STEAP3 FLOT1 SORD

6.42e-058782031637223481
Pubmed

A striking organization of a large family of human neural cadherin-like cell adhesion genes.

PCDH12 FAT2 PCDHGB2 CELSR1 PCDHGC3

6.57e-0572203510380929
Pubmed

Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.

PLXNB2 MDN1 PKP2 ASCC3 FLNA FNDC3A UPF1 IGF2BP1 SLC12A2 TRIM13

7.83e-053752031032788342
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

EPPK1 DDAH1 MARS1 COG4 FNDC3A UPF1 KLC4 IPO9 CDH2

8.13e-05304203932235678
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

ATP7A PLXNB2 DST PSD3 KLC2 EPB41L5 MYOF SLC12A2 STEAP3 FLOT1

8.18e-053772031038117590
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

DDAH1 NUP62 PSMD11 DST MDN1 NAE1 HSP90AA2P FLNA KRT18 IPO9 TSR1 AHNAK2

8.46e-055382031228524877
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

MARS1 ZNF184 PLXNB2 NUP205 PTRHD1 ATL2 HSPD1 FLNA KRT18 FNDC3A LETM1 IPO9 SLC12A2 STEAP3 ZMYM1 BCAM FLOT1 CDH2 ZNF239

8.91e-0512032031929180619
Pubmed

Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.

PCDH12 FAT2 PCDHGB2 CELSR1 PCDHGC3

9.06e-0577203510835267
Pubmed

Probing nuclear pore complex architecture with proximity-dependent biotinylation.

NUP62 NUP54 NUP205 MCM3AP PDZD2

9.06e-0577203524927568
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

DDAH1 ATP7A PLXNB2 ZDHHC13 MAP4K2 KLC2 EPB41L5 AIDA UPF1 SAR1A SLC12A2 BCAM TRIM13 CDH2

9.32e-057192031435337019
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

EPPK1 KIAA0319L CC2D1A PTCH1 PLXNB2 SLC29A2 KMT2C DST MDN1 MCM3AP ULK4 FLNA HUWE1 MYOF CELSR1 STEAP3 BCAM AHNAK2

9.34e-0511052031835748872
InteractionSCARB2 interactions

GEM DST HSPD1 FLNA KRT18 NAALADL2 LRCH3 GLMN MYOF NAT10 FLOT1

4.36e-0619520111int:SCARB2
InteractionYWHAH interactions

EPPK1 EXPH5 CC2D1A NUP62 NEK1 DST ALMS1 STARD9 PKP2 NR3C2 KIF2C VCPIP1 KRT18 TTC28 ARHGEF5 PSD3 KLC2 EPB41L5 HUWE1 SIPA1 KLC4 IPO9 SLC12A2 IKBKE LIMCH1 C9orf72 BECN1 AHNAK2

5.05e-06110220128int:YWHAH
InteractionKCNA3 interactions

CHL1 EPPK1 ATP7A MARS1 EXPH5 CC2D1A KMT2C DST PKP2 ASCC3 DNAH5 KIF2C VCPIP1 HSPD1 TTC28 NTRK2 PSD3 EPB41L5 CHD9 FNDC3A UPF1 LETM1 PPP2R1A RP1

6.71e-0687120124int:KCNA3
InteractionRHOA interactions

EPPK1 ATP7A KIAA0319L MCF2 PLXNB2 NUP205 BMPR1A MDN1 PKP2 ATL2 PLOD2 FLNA PLEKHG4 ARHGEF5 EPB41L5 ARHGEF18 FNDC3A UPF1 SIPA1 LETM1 MYOF IPO9 SLC12A2 STEAP3 WDR41 TRIM13 C9orf72 FLOT1

2.38e-05119920128int:RHOA
GeneFamilyEF-hand domain containing|Plakins

EPPK1 EVPL DST

3.23e-0581533939
GeneFamilyFibronectin type III domain containing

CHL1 NRCAM DSCAM ABI3BP TNC FNDC3A ROS1 MYBPC1

6.59e-051601538555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

CHL1 PXDNL NRCAM DSCAM NTRK2 HMCN1 MDGA1 MYBPC1

6.89e-051611538593
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

FRMPD4 MYO7B EPB41L4A EPB41L5

8.39e-045015341293
CoexpressionGSE4984_UNTREATED_VS_LPS_TREATED_DC_UP

PLXNB2 NRXN1 PLA2G4F ZDHHC13 KLC2 CPM LRCH3 CELSR1 CALCRL

2.87e-061512039M6498
CoexpressionBUSSLINGER_DUODENAL_TUFT_CELLS

KMT2C TMEM176B KRT18 CHD9 ZFHX3 BCAM FYB1

3.23e-06812037M40033
CoexpressionCUI_TCF21_TARGETS_2_DN

IRGM ATP7A RAPGEF5 MCF2 PCDH12 GEM DMXL1 KMT2C BMPR1A DST PLOD2 SLC36A4 CDKL2 PSD3 ARHGEF18 FNDC3A TNFRSF11B MYOF SLC12A2 CALCRL

1.18e-0585420320M1533
CoexpressionMURARO_PANCREAS_BETA_CELL

CHL1 EXPH5 PTCH1 GEM KMT2C DST GPR158 PKP2 DNAH5 PLOD2 HSPD1 NRCAM PSD3 CHD9 HUWE1 ERICH5 SHOC2 TNKS2 FLOT1 YME1L1 PDZD2

1.58e-0594620321M39169
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500

KLF12 ATP7A DMXL1 STARD9 PLOD2 CHD9 SLC5A3 PPP2R1A SLC12A2 ZKSCAN3 CEP295 CDH2 YME1L1 SENP7 MYBPC1

8.76e-0641319915gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000

EPB41L4A NRXN1 SCN9A PCDH15 PKP2 NIPBL TMEM176B NRCAM ABI3BP KRT18 TNC PSD3 EPB41L5 CPM MYOF CELSR1 OXCT1 ZFHX4 ZFHX3 BCAM C9orf72 FYB1 CDH2 SENP7

1.80e-0598419924Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

KLF12 ATP7A DMXL1 KMT2C STARD9 PLOD2 PRSS35 ABI3BP NTRK2 CHD9 FHIP2A SLC5A3 PPP2R1A SLC12A2 ZKSCAN3 CHSY3 CEP295 CALCRL YME1L1 SENP7 AHNAK2

2.11e-0579919921gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500

RBM44 ATP7A DMXL1 CHD9 SLC5A3 PPP2R1A SLC12A2 ZFHX4 ZKSCAN3 ZFHX3 CEP295 YME1L1 CDH10 MYBPC1

3.37e-0540919914gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500

ATP7A DMXL1 PPP2R1A IGF2BP1 SLC12A2 ZFHX4 ZKSCAN3 ZFHX3 CEP295 CDH2 YME1L1 CDH10 SENP7 MYBPC1

4.16e-0541719914gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

RBM44 ATP7A DMXL1 KMT2C ALMS1 DNAH8 VCPIP1 CDKL2 CHD9 HUWE1 SLC5A3 PPP2R1A SLC12A2 HMCN1 MEIOC ZKSCAN3 CEP295 C9orf72 YME1L1 SENP7

4.40e-0577619920gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasDevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000

CHL1 KLF12 ZGRF1 PTCH1 NEK1 OSBPL1A ELAC1 VCPIP1 ABI3BP TTC28 NTRK2 FNDC3A ZFHX4 HMCN1 ZFHX3 CALCRL TNKS2 CDH2 CDH10 SENP7

5.74e-0579119920gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

RBM44 ATP7A DMXL1 VCPIP1 CHD9 FNDC3A HUWE1 SLC5A3 PPP2R1A SLC12A2 ZFHX4 ZKSCAN3 ZFHX3 CEP295 CALCRL CDH2 YME1L1 CDH10 SENP7 MYBPC1

7.18e-0580419920gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000

KLF12 STARD9 NTRK2 CHD9 FHIP2A SLC5A3 ZKSCAN3 CHSY3 CEP295 YME1L1 SENP7

7.31e-0528119911gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000

CHL1 KLF12 RAPGEF5 BACH2 NEK1 ASCC3 ATL2 ALK NRCAM TTC28 NTRK2 HUWE1 IGF2BP1 SLC12A2 ZFHX4 ZFHX3 CHSY3 TNKS2 CDH2 CDH10

9.08e-0581819920gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000

UBL7 DDAH1 ATP7A PHF8 PTCH1 PLXNB2 PLOD2 KLHL6 PRSS35 FLNA TNC PSD3 CCNG2 MYOF IGF2BP1 ZFHX4 HMCN1 CDH2 CDH10 MYBPC1

1.05e-0482719920gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlasdev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000

DDAH1 ATP7A ZGRF1 PTCH1 GEM PKP2 PLOD2 KLHL6 PRSS35 KRT18 TNC PSD3 CA13 MYOF IGF2BP1 HMCN1 C9orf72 CDH2 CDH10 MYBPC1

1.49e-0484919920gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000

CHL1 DDAH1 BACH2 NEK1 FAT2 DST STARD9 OSBPL1A PRSS35 TNC PSD3 CPM HUWE1 ZFHX4 HMCN1 ZFHX3 CHSY3 LIMCH1 CDH2 ZNF239

1.52e-0485019920gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

KLF12 ATP7A DMXL1 KMT2C STARD9 PLOD2 VCPIP1 CHD9 FHIP2A SLC5A3 PPP2R1A SLC12A2 ZKSCAN3 CHSY3 CEP295 CALCRL YME1L1 AHNAK2 MYBPC1

1.69e-0479019919gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

RBM44 ATP7A DMXL1 KMT2C DNAH8 PLEKHG4 CDKL2 CHD9 SLC5A3 PPP2R1A SLC12A2 HMCN1 MEIOC ZKSCAN3 CEP295 CALCRL C9orf72 YME1L1 SENP7

1.83e-0479519919gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlaskidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500

DST CPM SLC12A2 CALCRL

1.93e-04311994gudmap_kidney_P0_CapMes_Crym_k3_500
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000

KLF12 ATP7A DMXL1 KMT2C STARD9 PLOD2 CHD9 FNDC3A FHIP2A SLC5A3 PPP2R1A SLC12A2 ZKSCAN3 ZFHX3 CEP295 CDH2 YME1L1 SENP7 MYBPC1

2.01e-0480119919gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000

ATP7A DMXL1 VCPIP1 CHD9 SLC5A3 CCNG2 PPP2R1A IGF2BP1 SLC12A2 ZFHX4 ZKSCAN3 ZFHX3 CEP295 CALCRL CDH2 YME1L1 CDH10 SENP7 MYBPC1

2.51e-0481519919gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000

CHL1 KLF12 BACH2 NEK1 ASCC3 ELAC1 ATL2 NRCAM TNC NTRK2 HUWE1 IGF2BP1 SLC12A2 ZFHX4 CHSY3 CALCRL TNKS2 CDH2 CDH10

2.62e-0481819919DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlasalpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2

BACH2 GPR83 MDN1 DNAH8 TTC28 ARHGEF18 CPM TSR1 IKBKE TNKS2 FYB1

2.75e-0432719911GSM538380_500
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000

ATP7A DMXL1 KMT2C CHD9 FNDC3A SLC12A2 CEP295 CDH2 YME1L1 SENP7

2.82e-0427519910gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000

ATP7A DMXL1 KMT2C ABI3BP SLC12A2 CALCRL

3.06e-04971996gudmap_developingGonad_e18.5_epididymis_1000_k4
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500

RBM44 ATP7A DMXL1 KMT2C ABI3BP CDKL2 SLC5A3 PPP2R1A SLC12A2 MEIOC CEP295 CALCRL

3.07e-0438719912gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000

BACH2 GEM DST OSBPL1A VCPIP1 TNC PSD3 CPM HUWE1 SLC12A2 ZFHX4 HMCN1 CORIN ZFHX3 CHSY3 LIMCH1 CALCRL CDH2 CDH10

3.44e-0483619919gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMPD4 MYO7B NRXN1 SCN9A PCDH15 DNAH5 NRCAM MROH2A ODAD2 PKHD1L1 ZFHX4 HMCN1 ROS1

3.20e-12184203132cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMPD4 MYO7B NRXN1 SCN9A PCDH15 DNAH5 NRCAM MROH2A ODAD2 PKHD1L1 ZFHX4 HMCN1 ROS1

3.20e-12184203132b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMPD4 MYO7B NRXN1 SCN9A PCDH15 DNAH5 NRCAM MROH2A ODAD2 PKHD1L1 ZFHX4 HMCN1 ROS1

3.20e-1218420313ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 DST PXDNL PRSS35 NRCAM ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1 CDH10

9.21e-12200203139b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CHL1 EXPH5 EVPL PLXNB2 FAT2 DST ZDHHC13 KRT18 TNC MYOF CELSR1 BCAM AHNAK2

9.21e-122002031397f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CHL1 EXPH5 EVPL PLXNB2 FAT2 DST ZDHHC13 KRT18 MYOF CELSR1 BCAM AHNAK2

1.49e-1020020312ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC PSD3 AFAP1 LIMCH1 CDH10

1.52e-0919320311fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC NAALADL2 MYOF AFAP1 LIMCH1

1.61e-091942031189b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

EXPH5 PLOD2 PRSS35 TMEM176B KRT18 EPB41L5 CPM MYOF CELSR1 LIMCH1 BCAM

2.00e-091982031185f424cd9bb3117c9e322031024aabb87696ce47
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 DST PXDNL NRCAM ABI3BP TNC MYOF AFAP1 LIMCH1 CDH10

2.10e-0919920311a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 DST PXDNL NRCAM ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

2.10e-091992031130d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 PXDNL PCDH15 PRSS35 NRCAM ABI3BP TNC PSD3 AFAP1 LIMCH1

2.22e-092002031164ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 DST PXDNL PRSS35 NRCAM ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

2.22e-0920020311b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 DST PXDNL PRSS35 NRCAM ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

2.22e-092002031150ca6550998e461ef26dd670351060bd940765a8
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 PXDNL PCDH15 PRSS35 NRCAM ABI3BP TNC PSD3 AFAP1 LIMCH1

2.22e-0920020311a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 DST PXDNL PCDH15 NRCAM ABI3BP TNC PSD3 AFAP1 LIMCH1

2.22e-0920020311bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCellLPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDAH1 PCDH15 PLOD2 ABI3BP TNC MROH2A TNFRSF11B SHQ1 CDH2 MYBPC1

3.13e-09158203107f5426585d0d299d2b48e5fcb349950feffdef33
ToppCellEpithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor

DDAH1 ATL2 DNAH5 EPB41L5 CPM CELSR1 CHSY3 ROS1 RP1 LIMCH1

1.58e-081872031081cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PXDNL PCDH15 NRCAM ABI3BP TNC MYOF AFAP1 LIMCH1 CDH10

2.03e-0819220310deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CHL1 EXPH5 DNAH5 TNC ODAD2 CELSR1 STEAP3 RP1 BCAM AHNAK2

2.13e-0819320310ea345d34440b25f65358a53dc72831998d1c3620
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1 CDH10

2.24e-081942031060622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster

CHL1 RAPGEF5 BACH2 EPB41L4A NRXN1 NRCAM CDKL2 NTRK2 PSD3 PDZD2

2.59e-081972031079b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster

CHL1 RAPGEF5 BACH2 EPB41L4A NRXN1 NRCAM CDKL2 NTRK2 PSD3 PDZD2

2.59e-0819720310d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

CHL1 PTCH1 DST PXDNL ABI3BP TTC28 TNC PSD3 MYOF LIMCH1

2.99e-0820020310a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells)

CAPN9 DDAH1 EVPL DNAH5 KRT18 CDKL2 LIMCH1 BCAM PDZD2

9.14e-08170203936c9f7f98612a72dc511c8da4358d67444f6bcf4
ToppCell356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells)

CAPN9 DDAH1 EVPL DNAH5 KRT18 CDKL2 LIMCH1 BCAM PDZD2

9.14e-0817020394cd3b7e43a061948084c01713ae141b5c2c07d89
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

RAPGEF5 NR3C2 PLA2G4F CDKL2 SLC19A3 CPM ROS1 LIMCH1 PDZD2

2.06e-0718720395df9e1f5ca32217af255e76e6fb5afa346337811
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1

2.25e-071892039a153b83314cf52808f685296cff8c95af3f4983d
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PTCH1 PXDNL PCDH15 NRCAM ABI3BP TNC MYOF LIMCH1

2.25e-0718920392a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 MCF2 NRXN1 SCN9A PCDH15 NRCAM DSCAM PCDHGC3 PDZD2

2.35e-0719020396c7e1086c0a274cd5527c3104106e372811c9905
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1

2.46e-071912039b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

DDAH1 EXPH5 NR3C2 EPB41L5 CPM CELSR1 ROS1 LIMCH1 PDZD2

2.57e-071922039499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1

2.57e-0719220396f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PXDNL PCDH15 NRCAM ABI3BP TNC MYOF AFAP1 LIMCH1

2.57e-071922039f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1

2.57e-071922039dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 GEM PCDH15 NRCAM ABI3BP TTC28 TNC MYOF AFAP1

2.57e-071922039162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCellFetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DDAH1 EXPH5 NR3C2 SLC19A3 EPB41L5 CPM CELSR1 ROS1 LIMCH1

2.69e-071932039a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 DST NRXN1 SCN9A ALK TMEM176B ZFHX4 HMCN1 CDH2

2.81e-071942039d429bb5e422a07bd92f0dc48cd51528e8b7d9a72
ToppCell3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 DST NRXN1 SCN9A ALK TMEM176B ZFHX4 HMCN1 CDH2

2.81e-071942039408dfc7060095972a54ae37ae8105521df6fbbee
ToppCell3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 DST NRXN1 SCN9A ALK TMEM176B ZFHX4 HMCN1 CDH2

2.81e-071942039bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

GEM DST PLOD2 NRCAM ABI3BP TTC28 TNC AFAP1 HMCN1

3.20e-071972039f1c8936986123a3151140c374fcd62d6705c530b
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 PXDNL PRSS35 ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

3.33e-0719820390a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCellControl_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type

EXPH5 PRSS35 TMEM176B KRT18 EPB41L5 CPM MYOF LIMCH1 BCAM

3.33e-0719820399b161285df7a4e51618f3517cfc5b8221ba55786
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 NRXN1 SCN9A PCDH15 NRCAM DSCAM NTRK2 CDH10 PDZD2

3.48e-07199203919a97e27a4758e794ce7246d295e112b47931a48
ToppCellMacroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-072002039961858738ce35db8760c8c2e136f8369bc444ccf
ToppCellMacroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-072002039f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCellMacroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-072002039cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCellMacroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-072002039c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 PXDNL PRSS35 ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

3.63e-0720020393bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 DST PXDNL ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

3.63e-07200203944a68bacdb3d5bf563bd35952176995850933a81
ToppCellMacroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-0720020394fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CHL1 DST PXDNL ABI3BP TNC PSD3 MYOF AFAP1 LIMCH1

3.63e-072002039dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellMacroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

CHL1 KLF12 GPR158 SCN9A PCDH15 DSCAM AFAP1 CALCRL PDZD2

3.63e-072002039310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

EPPK1 DDAH1 RAPGEF5 FLNA TNC NTRK2 ZFHX3 BCAM

7.42e-07160203829c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZNF140 CDC20B GPR158 TRPV1 TNFRSF11B LIMCH1 CALCRL CDH2

8.94e-071642038eae6d440877b292ad18dc4bd02802dda5b2f9c60
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHL1 RBM44 PTCH1 SLC29A2 DSCAM ABI3BP PKHD1L1 HMCN1

9.36e-0716520386d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHL1 RBM44 PTCH1 SLC29A2 DSCAM ABI3BP PKHD1L1 HMCN1

9.36e-07165203884f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCellsevere-CD4+_T_naive|severe / disease stage, cell group and cell class

IRGM EPPK1 NR3C2 ZFP28 AFAP1 ZNF565 FYB1 NEK11

1.03e-06167203802a8215fca59c357c1cdaa5738849eacf98c0bcc
ToppCellControl|World / group, cell type (main and fine annotations)

RAPGEF5 EXPH5 NR3C2 EPB41L5 NAALADL2 ROS1 LIMCH1 PDZD2

1.07e-061682038a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHL1 EPB41L4A DST NRXN1 SCN9A NRCAM BTBD18 CDH2

1.07e-06168203895dc690c1987b05685d36e6bb20eb79308696e30
ToppCelldroplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PKP2 PLA2G4F NRCAM DSCAM CA13 TNFRSF11B C9orf72 CDH2

1.73e-0617920384f20540bfbcefe0e83812be7ea542e8bb3bf19bc
ToppCellIPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class

PLOD2 ABI3BP KRT18 PKHD1L1 TNFRSF11B AFAP1 ZFHX4 CDH2

1.80e-0618020381fa54bf4dba72866b2295639d991af639341bc08
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DDAH1 RAPGEF5 CDKL2 CPM CORIN ROS1 LIMCH1 PDZD2

2.04e-0618320386847c1252d6bb105524f812658112517fd351eab
ToppCellIPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

GEM PLOD2 ABI3BP KRT18 PKHD1L1 TNFRSF11B AFAP1 CDH2

2.04e-0618320387df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IFT172 CC2D1A KMT2C NRCAM KRT18 ZFHX3 BCAM FYB1

2.21e-061852038686ed7550c6acd18e71e0076936ec5b07389adbd
ToppCellPBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters

EPB41L4A FAT2 DNAH8 CDKL2 PSD3 ODAD2 TNFRSF11B ZFHX4

2.21e-0618520384b5a7450fed912f340da16065c1e65d626dbe8d1
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NR3C2 ATL2 DNAH5 EPB41L5 CPM CELSR1 ROS1 RP1

2.30e-0618620382ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

RAB28 DST STARD9 PCDH15 ABI3BP TNC ZFHX3 LIMCH1

2.39e-06187203813731298bc562ec29582f5da1b4c97261284f6f1
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

KLF12 DDAH1 RAPGEF5 FLNA TNC TNFRSF11B MYOF CHSY3

2.49e-06188203834e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

EXPH5 DNAH5 EPB41L5 CELSR1 ROS1 RP1 LIMCH1 PDZD2

2.49e-061882038c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PXDNL PCDH15 NRCAM ABI3BP TNC AFAP1 LIMCH1

2.59e-061892038e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor

CAPN9 EPB41L4A DST EPB41L5 CHSY3 LIMCH1 BCAM PDZD2

2.59e-0618920385a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RAPGEF5 EXPH5 SCN9A NRCAM CPM CELSR1 RP1 CDH10

2.59e-0618920387659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

KLF12 DDAH1 GEM FLNA TNC TNFRSF11B MYOF CHSY3

2.59e-0618920386b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PCDH15 NRCAM ABI3BP TNC PSD3 MYOF AFAP1

2.69e-06190203845df8fee00f8949937863159d7aa042e72748d9b
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 FRMPD4 PXDNL PCDH15 ABI3BP TNC AFAP1 CDH10

2.69e-061902038841cd55861b43578d704418b9bc0af2e8b88323a
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

EXPH5 EVPL SCN9A DNAH5 CPM CELSR1 RP1 CDH10

2.80e-06191203860ff989fe99d243a3d52955223680cdd1f1917a4
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor

RAPGEF5 NR3C2 PLA2G4F CDKL2 CPM ROS1 LIMCH1 PDZD2

2.80e-061912038a0332a4ef629510fb313ec119195c44a3f704a80
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

DDAH1 EXPH5 EPB41L5 CPM CELSR1 RP1 LIMCH1 PDZD2

2.80e-061912038e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

DST PXDNL PKP2 PSD3 CORIN LIMCH1 CDH2 PDZD2

2.80e-06191203825f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 PXDNL PCDH15 NRCAM ABI3BP TNC MYOF AFAP1

2.91e-0619220383d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellEpithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor

RAPGEF5 NR3C2 PLA2G4F CDKL2 CPM ROS1 LIMCH1 PDZD2

2.91e-06192203858c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCellPCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RAPGEF5 EXPH5 SCN9A NRCAM CPM CELSR1 RP1 CDH2

2.91e-061922038b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCellLPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CHL1 GEM PCDH15 NRCAM ABI3BP TNC MYOF AFAP1

2.91e-0619220384e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NR3C2 PLA2G4F CDKL2 SLC19A3 CPM ROS1 LIMCH1 PDZD2

2.91e-061922038fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DDAH1 IFT172 PKP2 HSPD1 KRT18 NTRK2 SLC12A2 SORD

3.14e-06194203846e522ca59db545d1eb0c27cd4361f19d4f8f762
ToppCellfacs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHL1 EPPK1 EVPL SERPINB10 ALDH3B2 NTRK2 CA13 CELSR1

3.26e-06195203877128895db9221a64a171082d468ebcd6380c936
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KMT2C DST NRXN1 ASCC3 TTC28 HUWE1 TNKS2 CDH2

3.26e-0619520383e519cffa6144a62b06124642a14c9ff39b76554
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CHL1 PLXNB2 DST FLNA NRCAM TNC MDGA1 CDH2

3.39e-061962038b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCellLPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type

CHL1 PXDNL PLOD2 ABI3BP TNC CHD9 MYOF LIMCH1

3.52e-0619720380a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CHL1 DST NRCAM ABI3BP TNC MYOF AFAP1 LIMCH1

3.52e-061972038fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EPPK1 EVPL FAT2 KIF2C KRT18 TNC MYOF AHNAK2

3.52e-06197203861c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EPPK1 EVPL FAT2 KIF2C KRT18 TNC MYOF AHNAK2

3.52e-061972038dcabea5c50c133c9a4e294e447462d0393174ea7
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EPPK1 EVPL FAT2 KIF2C KRT18 TNC MYOF AHNAK2

3.52e-061972038fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EPPK1 EVPL FAT2 KIF2C KRT18 TNC MYOF AHNAK2

3.65e-061982038e06d41a7254a09e037ec404be2d8c352d5cbd7f4
ToppCellControl_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type

C5 TMEM176B KRT18 EPB41L5 CPM MYOF LIMCH1 BCAM

3.65e-061982038532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2
ToppCellControl_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type

DDAH1 C5 TMEM176B KRT18 EPB41L5 CPM LIMCH1 BCAM

3.65e-061982038827aa9d919bf6d670961e5501e17d351676127e3
ToppCellControl_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type

PRSS35 TMEM176B KRT18 EPB41L5 CPM MYOF LIMCH1 BCAM

3.65e-0619820389f972f217d2c39d4c0f7d0d4227d0fffe8535b9d
ToppCell10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

BMPR1A NRXN1 PLOD2 ABI3BP TNC ZFHX4 LIMCH1 CDH2

3.65e-061982038bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

GEM GPR83 STARD9 CPM MYOF CORIN MYBPC1

3.71e-0614020372c44e8cc5190226049be7ebc465d685393e701c4
Drugrosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A

RAB28 NR3C2 MAP4K2 ABI3BP TNC MYOF ZFHX4 BAZ2A ZKSCAN3 ZMYM1 SENP7 PDZD2

1.75e-07193203121233_DN
DrugVanadates

KLF12 EXPH5 BACH2 PSMD11 TUB GEM SCN9A NR3C2 C5 ZNF714 ALK COG4 ABI3BP TTC28 PLEKHG4 TNC PSD3 CA13 CHD9 ODAD2 TNFRSF11B CCNG2 AFAP1 STEAP3 ZFHX3 WDR41 BECN1 CDH10 ZNF239 AHNAK2 SORD

5.60e-07130220331ctd:D014638
Drugtroglitazone; Down 200; 10uM; PC3; HT_HG-U133A

KLF12 ZNF174 NR3C2 NIPBL ABI3BP TTC28 TNC PSD3 TNFRSF11B CCNG2 SENP7

1.11e-06189203111232_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A

MARS1 KIAA0319L PSMD11 VCPIP1 DSCAM PSD3 MYOF IKBKE ZKSCAN3 BCAM FYB1

1.75e-06198203114704_DN
Drugcarmustine; Down 200; 100uM; PC3; HT_HG-U133A

RAPGEF5 ZNF174 BACH2 NR3C2 TRPV1 TTC28 TNC CCNG2 IKBKE ZKSCAN3

1.01e-05194203106883_DN
DrugApomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A

GEM SCAF4 ALDH3B2 MAP4K2 ABI3BP TNC IPO9 ZFHX4 TNKS2 AHNAK2

1.10e-05196203101505_UP
DrugProadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A

RAPGEF5 KIAA0319L PCDH12 SCN9A TNC NTRK2 FNDC3A CCNG2 MYOF BAZ2A

1.10e-05196203105807_UP
Drug2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A

MARS1 NIPBL TNC TNFRSF11B LRCH3 MYOF AFAP1 BAZ2A LIMCH1 SENP7

1.15e-05197203101240_DN
DrugRetrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

EXPH5 EVPL NUP62 NEK1 ALMS1 DSCAM TDRD1 AFAP1 BAZ2A DNPEP

1.26e-05199203104946_DN
DrugPrilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A

CAPN9 PCDH12 GEM ALK OSGIN1 NTRK2 HUWE1 SLC5A3 IKBKE LIMCH1

1.26e-05199203104749_UP
DrugRicinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A

ZNF174 SCAF4 RAB28 C5 ALDH3B2 PSD3 CPM ZKSCAN3 STEAP3 BCAM

1.32e-05200203106206_DN
Drugtribromoethanol

PCDH15 NR3C2 SAR1A SORD

4.76e-05232034CID000006400
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A

MARS1 PHF8 PCDH12 PTCH1 GEM DSCAM ZNF780B CCNG2 FYB1

4.82e-0518720395678_UP
Drugradicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

GEM OSBPL1A OSGIN1 EPB41L5 SLC5A3 CCNG2 BAZ2A ZKSCAN3 LIMCH1

5.23e-051892039836_UP
Drugrottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MAP4K2 OSGIN1 TTC28 FNDC3A SIPA1 CCNG2 AFAP1 LIMCH1 BCAM

5.45e-051902039914_UP
Drug(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

SLC29A2 RAB28 MAP4K2 VCPIP1 DSCAM CCNG2 MYOF PPP2R1A IKBKE

6.16e-051932039982_UP
DrugCyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A

ZNF280A KLF12 GEM ALMS1 VCPIP1 PSD3 CCNG2 IKBKE DNPEP

6.16e-0519320394834_UP
DrugRapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A

KLF12 DDAH1 EXPH5 PSD3 TNFRSF11B MYOF ZFHX3 CDH10 JHY

6.66e-0519520392702_UP
DrugNaringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A

CAPN9 SCAF4 NEK1 TRPV1 EPB41L5 FNDC3A LIMCH1 BCAM NEK11

6.66e-0519520393286_DN
DrugRescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A

ATL2 DSCAM PSD3 FNDC3A SLC5A3 MYOF AFAP1 IPO9 JHY

6.66e-0519520394386_DN
DrugMifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A

EPPK1 NIPBL VCPIP1 TRPV1 ABI3BP TTC28 MYOF ZFHX4 JHY

6.93e-0519620395827_DN
Drugfluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A

PSMD11 PHF8 PTCH1 UPF1 SEC31B LETM1 IPO9 TSR1 STEAP3

6.93e-0519620391178_DN
DrugOxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A

KLF12 NEK1 TTC28 UPF1 TNFRSF11B AFAP1 IKBKE NEK11 JHY

6.93e-0519620395338_UP
DrugSulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A

ZNF174 BACH2 ATL2 ALK TRPV1 CPM LETM1 MYOF BAZ2A

7.21e-0519720394474_DN
DrugBenzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A

MARS1 ZNF174 NEK1 DSCAM TNC MYOF LIMCH1 BCAM NEK11

7.21e-0519720392822_DN
DrugBrinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CAPN9 MARS1 GEM TRPV1 PSD3 ZFHX4 IKBKE LIMCH1 TNKS2

7.21e-0519720395016_UP
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A

ZNF174 CC2D1A PSMD11 ALMS1 MAP4K2 VCPIP1 PSD3 FNDC3A TNFRSF11B

7.21e-0519720396026_DN
DrugAG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A

CHL1 ZNF280A RAPGEF5 KIAA0319L EPB41L4A HUWE1 CELSR1 BCAM AGBL2

7.50e-0519820396395_UP
Drug11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A

CAPN9 ZNF140 ZNF174 NIPBL DSCAM TTC28 PSD3 SIPA1 AFAP1

7.50e-0519820397514_DN
DrugDanazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

RAPGEF5 KIAA0319L SCAF4 ALDH3B2 ABI3BP PSD3 LIMCH1 TNKS2 AHNAK2

7.50e-0519820391538_UP
DrugCyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A

RAPGEF5 KIAA0319L COG4 PSD3 CPM UPF1 BAZ2A ZKSCAN3 LIMCH1

7.79e-0519920396740_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HG-U133A

CC2D1A PLXNB2 NEK1 NIPBL UPF1 BAZ2A IKBKE BCAM CDH2

7.79e-0519920391907_DN
DrugPhenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A

KLF12 CLEC4M PKP2 ALK TNC NTRK2 SIPA1 BAZ2A CDH2

7.79e-0519920396105_UP
DrugAlprenolol hydrochloride [13707-88-5]; Up 200; 14uM; PC3; HT_HG-U133A

RAPGEF5 MARS1 SLC29A2 NEK1 TRPV1 CCNG2 ZFHX3 FYB1 JHY

7.79e-0519920397141_UP
DrugPF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A

ZNF174 KIAA0319L NEK1 NTRK2 FNDC3A SIPA1 AFAP1 BCAM JHY

8.10e-0520020395917_DN
DrugSB 203580; Up 200; 1uM; MCF7; HT_HG-U133A

MARS1 ZNF174 KIAA0319L SCAF4 MCM3AP OSGIN1 PSD3 BAZ2A NEK11

8.10e-0520020396899_UP
DiseaseIntellectual Disability

CHL1 FRMPD4 NUP62 PCDH12 KMT2C NRXN1 PTRHD1 ASCC3 FHIP2A LETM1 PPP2R1A CDH2

5.14e-0544719712C3714756
Diseaseautism spectrum disorder (implicated_via_orthology)

ZNF280A NRXN1 PKP2 NR3C2 NRCAM DSCAM CHD9

7.60e-051521977DOID:0060041 (implicated_via_orthology)
Diseasevisceral heterotaxy (implicated_via_orthology)

CC2D1A OSBPL1A DNAH5 ODAD2

1.07e-04371974DOID:0050545 (implicated_via_orthology)
DiseaseDrug habituation

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0013170
DiseaseDrug abuse

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0013146
DiseasePrescription Drug Abuse

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C4316881
DiseaseSubstance-Related Disorders

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0236969
DiseaseDrug Use Disorders

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0013222
DiseaseDrug Dependence

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C1510472
DiseaseSubstance Dependence

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0038580
DiseaseSubstance Use Disorders

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0038586
DiseaseOrganic Mental Disorders, Substance-Induced

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.26e-041151976C0029231
DiseaseSubstance abuse problem

KLF12 PCDH15 DNAH8 NRCAM DSCAM LIMCH1

1.32e-041161976C0740858
Diseasepro-hydroxy-pro measurement

SERPINB10 NR3C2 ALK

1.54e-04161973EFO_0021132
Diseasesevere acute respiratory syndrome, COVID-19

KLF12 FRMPD4 NRXN1 NTRK2 PSD3 ARHGEF18 ODAD2 ZFHX3 CHSY3 WDR41 PDZD2

2.25e-0444719711EFO_0000694, MONDO_0100096
DiseaseGlioma

DMXL1 ALK NTRK2 PSD3 ROS1

2.99e-04871975C0017638
Diseaselymphocyte count

KLF12 EPPK1 DDAH1 EXPH5 BACH2 PLXNB2 ALMS1 MCM3AP NR3C2 ATL2 TTC28 PCDHGB2 PSD3 ARHGEF18 TDRD1 TNFRSF11B GLMN IKBKE CALCRL AGBL2 PCDHGC3 DNPEP

3.34e-04146419722EFO_0004587
DiseaseEpidermolysis Bullosa Simplex

EXPH5 DST

4.38e-0451972C0079298
DiseaseSARS-CoV-2 antibody measurement, response to COVID-19 vaccine

DDAH1 DSCAM NTRK2 MYBPC1

7.94e-04621974EFO_0803360, EFO_0803362
Diseaseglaucoma (biomarker_via_orthology)

GEM NTRK2 BECN1

8.49e-04281973DOID:1686 (biomarker_via_orthology)
Diseasesuberic acid measurement

PSD3 PDZD2

9.11e-0471972EFO_0010534
Diseasehereditary lymphedema (is_implicated_in)

CELSR1 CALCRL

9.11e-0471972DOID:0050580 (is_implicated_in)
Diseaseepidermolysis bullosa simplex (is_implicated_in)

EXPH5 DST

9.11e-0471972DOID:4644 (is_implicated_in)
DiseaseAlzheimer's disease 1 (implicated_via_orthology)

KLC2 KLC4

9.11e-0471972DOID:0080348 (implicated_via_orthology)
DiseaseMASA syndrome (implicated_via_orthology)

CHL1 NRCAM

9.11e-0471972DOID:0060246 (implicated_via_orthology)
Diseasesyndromic X-linked intellectual disability (implicated_via_orthology)

PHF8 HUWE1

1.21e-0381972DOID:0060309 (implicated_via_orthology)
Diseasepneumococcal meningitis

CELSR1 ROS1

1.21e-0381972EFO_1001114
DiseaseMalignant Glioma

DMXL1 NTRK2 PSD3 ROS1

1.25e-03701974C0555198
Diseasemixed gliomas

DMXL1 NTRK2 PSD3 ROS1

1.25e-03701974C0259783
Diseasealkaline phosphatase measurement

KLF12 PTCH1 NR3C2 MAP4K2 COG4 OSGIN1 TMEM176B PSD3 ZFP28 FHIP2A TNFRSF11B IGF2BP1 RP1 BCAM TNKS2 SENP7

1.36e-03101519716EFO_0004533
DiseaseManic

STARD9 DNAH8 NTRK2 SLC5A3

1.87e-03781974C0338831
Diseasearrhythmogenic right ventricular cardiomyopathy (is_implicated_in)

PKP2 CDH2

1.93e-03101972DOID:0050431 (is_implicated_in)
Diseasetestosterone measurement

MARS1 GPR83 NRXN1 FAM186A PTRHD1 OSGIN1 TMEM176B DSCAM TTC28 PSD3 GLMN ZFHX4 HMCN1 ZFHX3 TNKS2 JHY SORD DNPEP

2.33e-03127519718EFO_0004908
Diseasetriacylglycerol 56:2 measurement

ZFHX4 LIMCH1

2.34e-03111972EFO_0010429
DiseaseCognitive impairment

DMXL1 NAALADL2

2.34e-03111972HP_0100543
Diseaseciliopathy (implicated_via_orthology)

CC2D1A RAB28 MAP4K2

2.41e-03401973DOID:0060340 (implicated_via_orthology)
Diseasewellbeing measurement

ZNF184 PTCH1 NEK1 NR3C2 ASCC3 DSCAM ODAD2 C6orf15 ZKSCAN3 STEAP3 ZFHX3 AGBL2

2.50e-0369219712EFO_0007869
Diseaseoptic disc size measurement

KLF12 PTCH1 ABI3BP LIMCH1 CDH2 PDZD2

2.62e-032051976EFO_0004832
Diseaseniacinamide measurement

OSBPL1A NAALADL2

2.80e-03121972EFO_0010511
Diseasevon Willebrand factor measurement, coagulation factor measurement

EPB41L4A CDH2

2.80e-03121972EFO_0004629, EFO_0004634
Diseaseurate measurement, bone density

KLF12 BACH2 BMPR1A NR3C2 DNAH8 DSCAM TTC28 PSD3 NAALADL2 JHY PDZD2

3.12e-0361919711EFO_0003923, EFO_0004531
DiseaseShort Rib-Polydactyly Syndrome

IFT172 NEK1

3.30e-03131972C0036996
DiseaseN-acetylglutamine measurement

ALMS1 PSD3

3.30e-03131972EFO_0800017
DiseaseBardet-Biedl Syndrome

IFT172 ALMS1

3.30e-03131972C0752166
Diseaseobesity (implicated_via_orthology)

CAPN9 PLXNB2 TUB ALMS1 ZFHX4 ZFHX3

3.32e-032151976DOID:9970 (implicated_via_orthology)
Diseasenasopharyngeal neoplasm

OSBPL1A C5 NTRK2 C6orf15 ZFHX3

3.51e-031511975EFO_0004252
Diseasedystonia (is_implicated_in)

NUP54 SHQ1

3.83e-03141972DOID:543 (is_implicated_in)
DiseaseKartagener syndrome (implicated_via_orthology)

DNAH5 ODAD2

3.83e-03141972DOID:0050144 (implicated_via_orthology)
DiseaseSaldino-Noonan Syndrome

IFT172 NEK1

3.83e-03141972C0036069
DiseaseMajewski Syndrome

IFT172 NEK1

3.83e-03141972C0024507
Diseasecaudate nucleus measurement, functional brain measurement, response to reward

CHL1 PSD3 CELSR1

3.83e-03471973EFO_0007849, EFO_0008387, EFO_0008396
DiseaseCraniofacial Abnormalities

PTCH1 BMPR1A NRXN1 NIPBL LETM1

4.04e-031561975C0376634
DiseaseCardiomyopathy, Dilated

ALMS1 PKP2 NR3C2

4.06e-03481973C0007193
Diseaselung adenocarcinoma (is_implicated_in)

PTCH1 KMT2C ZFHX3

4.31e-03491973DOID:3910 (is_implicated_in)
Diseaseresponse to platinum based chemotherapy, magnesium measurement

PCDH15 PSD3

4.40e-03151972EFO_0004647, EFO_0004845
DiseaseRhabdomyosarcoma

PTCH1 ALK

4.40e-03151972C0035412
Diseaseosteoarthritis (implicated_via_orthology)

ATP7A BMPR1A

4.40e-03151972DOID:8398 (implicated_via_orthology)
Diseaseeosinophilic esophagitis

DDAH1 NEK1 NRXN1 ERICH5 NAALADL2

4.86e-031631975EFO_0004232
DiseaseBipolar Disorder

RAPGEF5 NRXN1 STARD9 ULK4 DNAH8 DSCAM NTRK2 SLC5A3 MDGA1

4.97e-034771979C0005586
Diseasecutaneous Leishmaniasis

SERPINB10 PXDNL

5.00e-03161972EFO_0005046
Disease4-acetamidobutanoate measurement

PLXNB2 PSD3

5.00e-03161972EFO_0021003
DiseaseRetinitis Pigmentosa

IFT172 TUB ARHGEF18 RP1

5.27e-031041974C0035334
DiseaseMajor Depressive Disorder

RAPGEF5 CC2D1A NR3C2 ABI3BP NTRK2 IKBKE

5.99e-032431976C1269683
Diseaseamino acid measurement

ALMS1 ULK4 NR3C2 C5 ALK OSGIN1 PSD3 ODAD2 SHOC2 BCAM TNKS2

6.10e-0367819711EFO_0005134
DiseaseEpilepsy

PCDH12 SCN9A FLNA SLC12A2

6.22e-031091974C0014544
Diseaseurinary metabolite measurement

DDAH1 ALMS1 PSD3 PKHD1L1 SORD DNPEP

6.22e-032451976EFO_0005116
Diseasebiliary atresia

SCN9A AFAP1 RP1

6.27e-03561973MONDO_0008867
DiseaseCiliopathies

NEK1 PCDH15 DNAH5 DNAH8

6.42e-031101974C4277690

Protein segments in the cluster

PeptideGeneStartEntry
SDLIPKVLTLNVGDE

TDRD1

481

Q9BXT4
ETNADIPLQGKSIVD

nan

341

A8MVM7
EQLQGLPSETKVIIQ

ZNF280A

481

P59817
KIGPILDNSTLQSEV

PPP2R1A

546

P30153
LVGQTKNDLVVSLPE

BACH2

66

Q9BYV9
DPSETLQGELILKSA

ARHGEF18

861

Q6ZSZ5
LATAIQEELEKGTPE

DNPEP

201

Q9ULA0
LNLINESPALGKEET

ADGRG4

2476

Q8IZF6
EGLTELNSTAIKPQV

COG4

606

Q9H9E3
EVVLEKALLSTPNGA

BAZ2A

1611

Q9UIF9
ELKITQQGTDPLVLA

AFAP1

216

Q8N556
NILKRTQPGSSEEAE

ARHGEF5

1326

Q12774
EEGILTQSENQVKEP

ALMS1

191

Q8TCU4
LLTSKPVAQDQESLG

ALMS1

3101

Q8TCU4
KGLSLIEATPENDNT

CCNG2

36

Q16589
VSVKDLNGIDLTPVQ

AIDA

191

Q96BJ3
IGEPNSQLQKITDTL

CA13

151

Q8N1Q1
LDSLTPANEDQKIGI

HSPD1

451

P10809
DNGIPQKSDTTTLEI

CELSR1

866

Q9NYQ6
ISQGTEKVLAEVLPQ

ALDH3B2

61

P48448
IGADLVLQISKESPQ

SORD

216

Q00796
TLPVSSLVEEGEKQN

DMXL1

2376

Q9Y485
ANQIKELVPELSLDT

ATP7A

136

Q04656
EESETQPLVALVGNK

RAB28

116

P51157
TKALDISNPEVVELG

RBM44

206

Q6ZP01
TEDIPIILVGNKSDL

GEM

181

P55040
LTEQKETSVLGPAEA

NUP205

1351

Q92621
PKGEQELEISESASL

PCDH12

136

Q9NPG4
IVKLDPGDDISSLQQ

MAP4K2

46

Q12851
QGTDPISQTKVAELL

KLC4

496

Q9NSK0
ITPDVIKESENIQLG

MDGA1

336

Q8NFP4
SGLTVEVDAPKSQDL

KRT18

231

P05783
IASNNKLVSLPEEIG

LRCH3

156

Q96II8
ADILVQPTLEENKGT

MDN1

3586

Q9NU22
QITTQPSDGLEEKLD

KMT2C

2676

Q8NEZ4
PSQKTGDLVEILNGE

KLHL6

31

Q8WZ60
VEIISDQLPKVESGN

NR3C2

961

P08235
KEEGQLLSVEALPES

JHY

136

Q6NUN7
EILQEPSGTNKDESL

NEK1

901

Q96PY6
EIGELNDINITTPSK

CHL1

961

O00533
ENGTLEIPVAQKDST

NRCAM

506

Q92823
IIKGTLIDSSINEPQ

LGALS16

21

A8MUM7
SQGQSILEDEKLLIS

GPR158

1076

Q5T848
KNVSVQPEISEGLAT

KIAA0319L

246

Q8IZA0
VSAGESVQITLPKNE

KIAA0319L

311

Q8IZA0
IPESSQVIGLDAAKQ

DST

1901

Q03001
KLIQGSELPELTDSV

DST

2751

Q03001
PNLETVKEIGLESST

DST

3331

Q03001
IGNLNESVTPADLEK

IGF2BP1

6

Q9NZI8
ADGNLPEVISNIKET

IRGM

11

A1A4Y4
EIPDTINDLQGSTKV

MCM3AP

1536

O60318
QGVQESLSKLLEELS

IKBKE

636

Q14164
QSETLKDTAPVLEGL

LETM1

521

O95202
LLTTAQAKPGETQEE

BECN1

46

Q14457
NELLDNDSEKGLTIP

C2CD6

401

Q53TS8
EEISGPLTSANKITL

FLOT1

366

O75955
LILSKVGVSQQPEDS

PLXNB2

1556

O15031
EVTVLDNGEPSLKST

FAT2

1211

Q9NYQ8
SIPEELAKNSVVGNL

PCDHGB2

36

Q9Y5G2
SVDVPKNGESVLENL

PDZD2

1761

O15018
DPITGQKLLEAQAAT

EVPL

1851

Q92817
AVLETITNIQPKESG

DNAH8

4196

Q96JB1
DLQVKPGESLEVIQT

FYB1

726

O15117
LQEDIVGSLKSTPEN

NIPBL

581

Q6KC79
KEISVGELNPNETVQ

NEK11

61

Q8NG66
KLQLGEETQSDEPNL

EXPH5

1516

Q8NEV8
NPEILLTLEEKTAAN

MEFV

256

O15553
SSQVLPVDSGEVKLD

NRXN1

191

Q9ULB1
LLSPLEELVKEQSGT

NUP62

406

P37198
RQTLTVLIKDNGEPS

PCDHGC3

641

Q9UN70
IKSLGLAVSSVENDP

OC90

266

Q02509
LEKSQVPASEVITNG

PLA2G4F

161

Q68DD2
EGKTTELTALLNRPN

OSBPL1A

151

Q9BXW6
LQSGKTDLSSVEPIV

GPR83

406

Q9NYM4
ISGLPTIDIDDLKSN

HUWE1

4251

Q7Z6Z7
SVDQLEKEIELPSGQ

NAT10

876

Q9H0A0
TIKIVGPEENLSQAE

PLOD2

356

O00469
LSQDKPVEISVLAGE

HMCN1

1081

Q96RW7
IKGANSDLPEEVTVL

HMCN1

2871

Q96RW7
PDSTKIAIGQTDNII

IFT172

76

Q9UG01
QGLDPASQTKVVELL

KLC2

481

Q9H0B6
QTLTVNVEGTKTLPD

NUP54

221

Q7Z3B4
NLPAGTTILQIEAKD

PCDH15

831

Q96QU1
LPQDTSVEVGKNINI

PXDNL

516

A1KZ92
TLPKTDSGNEDLVII

UPF1

346

Q92900
EITSSQPLDGQEDKL

BTBD18

596

B2RXH4
DIKPENILVSQSGVV

CDKL2

126

Q92772
VVEEKVSQNLGTNLP

C6orf15

31

Q6UXA7
EEEKASVLGQLASLP

CPLX3

116

Q8WVH0
KVLLTGTPLQNTVEE

CHD9

1021

Q3L8U1
TSSGPILAEEAVLKQ

EPB41L5

711

Q9HCM4
VTSDGKDPEITNLIN

CPM

101

P14384
LIQTISAVDKDDPLG

CDH10

506

Q9Y6N8
SLSIEGPSKVDINTE

FLNA

2081

P21333
KGSSLQNDEIPVSLI

FRMPD4

836

Q14CM0
VGEETNITLNDLKPA

FNDC3A

326

Q9Y2H6
ISLPTGISANEEDLK

C5

1426

P01031
LLAPENLVEKEISGS

ATL2

331

Q8NHH9
PVGESLKDLIDQSQS

BMPR1A

201

P36894
EATKPTQQSLVGVLE

CC2D1A

416

Q6P1N0
VKELAVTLQGPEDNT

AGBL2

251

Q5U5Z8
GLGEPSVTKLIQEQE

CORIN

731

Q9Y5Q5
IDDKQLTPELGGTLQ

MCF2

71

P10911
LKSSGDINDSILQPE

CDC20B

206

Q86Y33
PVAQGLKEALVDTLT

IPO9

16

Q96P70
VKTELLESEQGSPNV

KLF12

31

Q9Y4X4
ELPKSSLQRLEEGTQ

FAM186A

916

A6NE01
PNVISEDTLKGQDSL

FHIP2A

186

Q5W0V3
ISKENESPEILEGSQ

ERICH5

221

Q6P6B1
TLLVQGSPELKTAEI

BCAM

441

P50895
TNPQIKLSLTEKDEG

CAPN9

376

O14815
NSGKEQEINETLPIT

CEP295

471

Q9C0D2
IQKELVDPSGLSEEQ

EPB41L4A

556

Q9HCS5
INEDTTKDLSIGNPI

SCAF4

771

O95104
GPDKNLTSAEITNEI

SLC19A3

41

Q9BZV2
IPGNLSKEEEELSSQ

KIF2C

616

Q99661
ESPEDSIQLGVTRNK

CALCRL

26

Q16602
SGQLSVTKPLDREQI

CDH2

216

P19022
SKLGLQVVELPADES

DDAH1

56

O94760
IPNKQDQTLTIVDTG

HSP90AA2P

81

Q14568
APKTEQVLLSDGEIT

C9orf72

46

Q96LT7
LTLANNPETLGKIED

DNAH5

241

Q8TE73
DVLDTILGIQPKDTS

DNAH5

4331

Q8TE73
SPLELKQDNGSIEIN

LIMCH1

601

Q9UPQ0
KLTEAPGVSILDQDL

OSGIN1

56

Q9UJX0
PGTKQNDDSRILTDI

RP1

1721

P56715
QFILLGLSEKPEQET

OR1M1

11

Q8NGA1
VISLQLPGEDNESIK

MROH2A

906

A6NES4
ELGEIKNITTTQPSL

DSCAM

1136

O60469
KNITTTQPSLELDGL

DSCAM

1141

O60469
EEPSGKQISQSILLL

GLMN

111

Q92990
GLVSNILEEQDKSQP

MEIOC

136

A2RUB1
KDDGISLLISDTQPE

SENP7

251

Q9BQF6
ETKAELLQSDENGIP

SLC29A2

236

Q14542
PDETTLKELAETLQQ

PTRHD1

86

Q6GMV3
LTLDEPDKSQGQDLQ

NBPF8

96

Q3BBV2
STLLKEVPSGLQLEQ

PLEKHG4

286

Q58EX7
KAIETLVGLLTDQPE

ODAD2

756

Q5T2S8
LNTPEDVQALVSGKL

PSMD11

261

O00231
PETLRDLAQGTKTLQ

EPPK1

3261

P58107
TPKEEGANVLTTEAL

PTCH1

161

Q13635
NGQLLPEVIIDKATS

SCN9A

641

Q15858
ELQPNDLVISKSLEA

RAPGEF5

296

Q92565
TNQLTKIPEDVSGLV

SHOC2

411

Q9UQ13
VQDEVQGVTLLPTTK

SIPA1

791

Q96FS4
ELGEQLKTTVQVSEP

SHQ1

541

Q6PI26
SEDSIKGLQPEDVNL

SLC5A3

591

P53794
DETISNVPILILGNK

SAR1A

121

Q9NR31
EIPITKDIDGLLSQA

SEC31B

556

Q9NQW1
ADLINAGKETVTILP

OXCT1

361

P55809
LSEGSAESKLVVEPQ

STARD9

3146

Q9P2P6
GDTDKVIPSQESVQL

OVCA2

176

Q8WZ82
SSQPLNEEGSEKRLL

TMEM176B

236

Q3YBM2
LTISGEDKILQNTAP

ALK

636

Q9UM73
PSTDLELQAGQLDVK

AHNAK2

1381

Q8IVF2
ELPINGETQKTISLD

ASCC3

181

Q8N3C0
NTEVSKEDQQLGVIP

CHSY3

436

Q70JA7
LTQLKAAVGELPDQS

CLEC4M

231

Q9H2X3
SELQEGDSLTVPTKL

C12orf50

156

Q8NA57
LAAPNLTVEEGKSIT

NTRK2

201

Q16620
SEVEIQDTVKAGLQP

PNMA5

31

Q96PV4
ETQPGLVTIKNLAVD

ZFP28

226

Q8NHY6
GTQPLLLAKEEDVAT

ZFHX4

1141

Q86UP3
QKDILPNLVSLDVSG

ZYG11B

261

Q9C0D3
SVLVDNLPGTKVNAE

TNFRSF11B

221

O00300
GIAVSKQDPITSLEQ

ZNF714

16

Q96N38
GLSISKPDVVSLLEQ

ZNF565

86

Q8N9K5
VPSEENNLVGTLKIS

TSR1

261

Q2NL82
LVDVDKLSLPQDTGT

TRIM13

291

O60858
SSLDIQNVKGETPLD

ZDHHC13

241

Q8IUH4
LEKTGSQLGEQELPD

ZNF174

146

Q15697
LAGKILVDVSNPTEQ

STEAP3

106

Q658P3
VTLIEDGKNDSLPSE

TRPV1

596

Q8NER1
QDLVLEPTQNITTKG

PRSS35

101

Q8N3Z0
LQGQEELLSSQEKSP

SLC12A2

931

P55011
AKEPEIGNLNVSDIT

TNC

1436

P24821
NKESLDQIIVATPGL

UBL7

136

Q96S82
ILKGLEELEFPQTSQ

SRRD

271

Q9UH36
TQEIGQKTSVSVLEP

ROS1

906

P08922
VLENGVTISPQDVLK

ELAC1

226

Q9H777
TLDITEQTKGKPNLE

PKHD1L1

621

Q86WI1
GQESESQLPTKIILT

VCPIP1

681

Q96JH7
GSSISKPDVITLLEQ

ZNF780A

46

O75290
GSSISKPDVITLLEQ

ZNF780B

46

Q9Y6R6
NTPLDLVKDGDTDIQ

TNKS2

626

Q9H2K2
TGKLSPETQSAIEQE

YME1L1

706

Q96TA2
LPVKLVVLGSSQESN

TTC28

1616

Q96AY4
GILSESDIQEDNKIP

ZGRF1

426

Q86YA3
GLSISKPDVVSLLEQ

ZNF140

46

P52738
LTPESQGLLKVEDVA

ZKSCAN3

206

Q9BRR0
DEVILKPTGNQLTVE

PHF8

136

Q9UPP1
IPLDSAKESLGTQLQ

ZBED9

156

Q6R2W3
SQLGLLDEIKTEPDN

ZMYM1

16

Q5SVZ6
LQVKLVSDGQELASP

ZNF239

116

Q16600
RTGQQLTSDQLPIKE

ABI3BP

1016

Q7Z7G0
PEDLLNGLKVTDTQE

TTC1

11

Q99614
QSIGQAPESISEKEL

NAE1

366

Q13564
LGTVLESQAQDLKTP

WDR87

2451

Q6ZQQ6
SLQNEIAKETLPDLV

PKP2

761

Q99959
GSTEILEKETPENLS

PSD3

561

Q9NYI0
AEDKSEAQGPVQILT

TUB

141

P50607
TATETKALEEGLTPQ

MARS1

316

P56192
DEIKGSITLNLPQDV

SLC36A4

331

Q6YBV0
QTEGKIQNLLPDDSV

SERPINB10

161

P48595
LSDTGISALVEIPKN

WDR41

171

Q9HAD4
SIGLQVSKPDVISQL

ZNF184

66

Q99676
VSKPDVISQLEQGTE

ZNF184

71

Q99676
GSLKTVIAQDENLPE

ULK4

81

Q96C45
EDLGKNILPSASTEQ

ZFHX3

1326

Q15911
TKLSGEVILQIANEP

NAALADL2

631

Q58DX5
LNISPGKDVNADTIL

MYO7B

1896

Q6PIF6
LPLTEGKANVTVLDT

MYOF

706

Q9NZM1
LTPLTDQTVNLGKEI

MYBPC1

436

Q00872